estrogens progestins pharm Flashcards
estrogen/progesterone metabolism
•degraded rapidly on 1st-pass through liver; analogs that have reduced hepatic degradation have been developed for oral use
- Define the principal estrogens/progestins in humans
Estradiol (E2):most abundant and potent estrogen in menstruating wome. Estrone (E1): 2nd most potent estrogen, the predominant estrogen during menospause. Estriol (E3): weak estrogen
- Define the estrogen-like compounds in our environment.
A. phytoestrogens - occur in plants, fruits, veggies. have estrogenic and antiestrogenic activities: 1) isoflavones are most potent (genistein and diazein in soybeans, chickpeas, lentils) 2) coumestans: split peas, lima beans, 3) lignans (enterolactone and enterodiol found in flaxseed, lentils, grains, fruits, veggies, ). B. bisphenol A- a synthetic compound used in plasticizers; has weak affinity but its bioaccumulation in the environment has raised concerns about potential toxicity
Sites of estrogen synthesis in pre vs post menopausal women (and men)
Premenopausal: ovarian theca and granulosa cells. Men and postmenopausal: adipose tissues (estrone is synthesized from androstenediol secreted by the adrenal cortex) and conversion of test to estradiol via aromatase
compare levels of estrogen in pre vs post menopausal and men
premenopausal: early follicular (40-200 pg/ml); preovulatory (250-500 pg/ml); midluteal (100-150 pg/ml). Post menopausal/ men: <20pg/ml
biosynthetic pathway of estrogen production
cholesterol > pregnenolone > progesterone > androstenedione > estrone (aromatase)> estradiol. OR androstenedione > testosterone > estradiol (aromatase)
two cell theory of estrogen synthesis
the theca cells secrete androgens that diffuse to the granulosa cells to be aromatized to estrogens.
Tissue locations of aromatase
granulosa cells, adipose tissue, muscle and brain
Estrogen feedback regulation
estrogen feeds back primarily at the level of the pituitary to inhibit LH/FSH secretion.
- Describe the mechanism of action of estrogens.
Estrogen (E) binds to ER and facilitates dimerization and interaction with estrogen response element (ERE) sequences in DNA. The ER-DNA complex recruits co-activators SWI/SNF and SRC-1. SRC-1 has histone acetyltransferase activity that alters chromatin structure. This remodeling facilitates the exchange of the recruited proteins such that other co-activators (p300 and TRAP) bind to the gene promoter and recruit proteins that comprise the general transcription apparatus (GTA) resulting in synthesis of mRNA.
Describe MOA of estrogen receptor antagonists
ie. Tamoxifen. Binds ER facilitating dimerization, but recruits co-repressors NcOR. NcOR recruits histone deacetylase I which stabilizes nucleosome and prevents interaction with the general transcription apparatus
The recruitment of factors by the estrogen receptor depends on
The ligand and tissue that the receptor is in
Types of estrogen receptors and which hormones bind to them
ER alpha and beta: 17b-estradiol bind equally to Era and Erb. Estrone has higher affinity for Era. Phytoestrogens genistein and coumestrol have higher affinity for Erb.
tissue distribution of estrogen receptors
ER b: granulosa cells, kidney, intestinal mucosa, lung, bone marrow, brain, prostate. ER a: endometrium, breast cancer cells and ovarian stroma
Therapeutic uses of estrogens
Hypogonadism (plus progestin if uterus intact), menopause, menopause (plus calcium, Vit D and bisphosphanates), contraception (plus progestin to inhibit production of LH/FSH and GnRH), PCOS (plus spironolactone)
Estrogen use in menopause
alleviate vasomotor instability, emotional lability, sleep disturbances, atrophy of estrogen-dependent tissues, and osteoporosis
Modifications to estradiol to increase lipid solubility and decrease degradation by liver
Estradiol is esterified at 17-beta position (R3) to increase lipid solubility. Adding an ethinyl group at position 17 (R2) decreases degradation by the liver.
List the esterified estrogens
estradiol valerate and estradiol cypionate